Breakthrough Infections in Lupus Patients Down With COVID Booster
WEDNESDAY, July 13, 2022 -- For patients with systemic lupus erythematosus (SLE), the risk for breakthrough COVID-19 infection is lower among those who have received a booster vaccine dose after initial vaccination, according to research published... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 13, 2022 Category: Pharmaceuticals Source Type: news
COVID Boosters Can Help People With Lupus
WEDNESDAY, July 13, 2022 -- People with lupus benefit from a COVID-19 booster shot after full vaccination, with a new study showing they are half as likely to experience a COVID infection afterward. " Our study results offer people living with... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 13, 2022 Category: General Medicine Source Type: news
COVID Boosters Can Help People With Lupus
Title: COVID Boosters Can Help People With LupusCategory: Health NewsCreated: 7/13/2022 12:00:00 AMLast Editorial Review: 7/13/2022 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - July 13, 2022 Category: Rheumatology Source Type: news
Mobile Health Apps for SLE and Lupus Nephritis Mobile Health Apps for SLE and Lupus Nephritis
There are numerous mobile health apps specifically intended for patients with SLE and lupus nephritis, but how useful are they?Arthritis Research & Therapy (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 12, 2022 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news
Picture of Acute Systemic Lupus
Title: Picture of Acute Systemic LupusCategory: ImagesCreated: 1/5/2010 2:17:00 PMLast Editorial Review: 7/9/2022 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - July 9, 2022 Category: Rheumatology Source Type: news
Abortion Restrictions May Be Making It Harder for Patients to Get a Cancer and Arthritis Drug
Soon after she started taking the drug methotrexate in February, Jennifer Crow noticed a significant improvement in her inflammatory arthritis pain. Since then, she’s taken the drug weekly. So her stomach dropped on July 1, when she got an automated call from her pharmacy saying her methotrexate refill for the month hadn’t been approved.
Crow, who is 48 and lives in Tennessee, was confused by the disruption, until she saw on social media that other people were reporting similar denials. Methotrexate—which in high doses is used as a chemotherapy drug—is sometimes prescribed to induce abortions, compl...
Source: TIME: Health - July 6, 2022 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized abortion healthscienceclimate Source Type: news
How Changing Your Diet Could Have a Major Impact on Managing Lupus Symptoms
After Jewell Singletary was diagnosed with lupus, she developed rheumatoid arthritis as well—a common pairing, since both are autoimmune conditions—and had to use a cane to navigate her college campus. When she graduated, the now 38-year-old New Jersey resident decided to be more focused on supporting her health, in an effort to maintain her mobility as she began her career.
She started in the kitchen.
First to be tossed were sugary drinks, fried foods, and highly processed options, she says. Once she eliminated them, it didn’t take long before she could discard one more important item: her cane.
[time-br...
Source: TIME: Health - June 29, 2022 Category: Consumer Health News Authors: Elizabeth Millard Tags: Uncategorized Diet & Nutrition freelance healthscienceclimate Source Type: news
Early lupus patient data sends Kezar Life Sciences' stock soaring after-hours
A Peninsula drug developer's stock ballooned more than 100% in after-hours trading Monday after it disclosed early data from a midstage clinical trial of a drug designed to treat the autoimmune kidney disease lupus nephritis.
Kezar Life Sciences Inc. (NASDAQ: KZR) said lupus nephritis patients responded well — including some with a complete response — after 24 weeks of treatment with the company's drug zetomipzomib.
Lupus nephritis is a type of kidney disease caused by systemic lupus, where… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - June 28, 2022 Category: Biotechnology Authors: Ron Leuty Source Type: news
Does Sunlight Trigger Lupus?
(MedPage Today) -- Whether exposure to ultraviolet (UV) radiation from the sun can cause new-onset systemic lupus erythematosus (SLE) wasn't settled by data from a large, long-running epidemiologic study, but the trends indicated that it could... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - June 22, 2022 Category: American Health Source Type: news
Guideline: Timing Is Everything for RA and Lupus Patients Needing Joint Replacement
(MedPage Today) -- Conventional disease-modifying antirheumatic drugs (DMARDs) may usually be continued in patients with inflammatory arthritis or systemic lupus erythematosus (SLE) undergoing total knee or hip replacement, but the same is not... (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - June 21, 2022 Category: Primary Care Source Type: news
Picture of Systemic Lupus Erythematosus 2
Title: Picture of Systemic Lupus Erythematosus 2Category: ImagesCreated: 2/25/2010 9:40:00 AMLast Editorial Review: 6/21/2022 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - June 21, 2022 Category: Rheumatology Source Type: news
New Blood Tests Approved for Lupus, Systemic Sclerosis Diagnoses New Blood Tests Approved for Lupus, Systemic Sclerosis Diagnoses
The Food and Drug Administration has approved a new diagnostic blood test to detect monospecific Ribosomal P antibodies to support a diagnosis of systemic lupus erythematosus.WebMD Health News (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - June 17, 2022 Category: Pathology Tags: Rheumatology News Source Type: news
Deucravacitinib and Orelabrutinib Perform Well in Lupus Trials Deucravacitinib and Orelabrutinib Perform Well in Lupus Trials
Disease activity was reduced by treatment with either of the novel investigational agents in two separate early clinical trials, with further trials planned.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - June 10, 2022 Category: Dermatology Tags: Rheumatology News Source Type: news
The Shocking Truth About Electric Baths
The galvanic bath was once used to treat lupus and rheumatoid arthritis but was later declared quackery. Now, the practice is making a comeback. (Source: WebMD Health)
Source: WebMD Health - June 9, 2022 Category: Consumer Health News Source Type: news
Continuing, Stopping Immunosuppression Tested in Lupus Nephritis Continuing, Stopping Immunosuppression Tested in Lupus Nephritis
Risk of renal relapse and SLE flares was greater in patients with lupus nephritis who discontinued rather than continued immunosuppressive therapy.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 9, 2022 Category: Consumer Health News Tags: Rheumatology News Source Type: news
